BUSINESS UNITS / Generics API

We are making a difference with affordable and high-quality APIs manufactured with the highest GMP standards.

Building on our strong capabilities in chemical development and manufacturing, Laurus Labs has developed a wide range of in-house APIs and intermediates. We focus on chemistry where we can make a difference and combine innovation with efficiency to develop cost-effective and hence affordable processes. We regularly invest in building capacities to ensure reliable and sustained supply.​

Laurus is one of the world’s leading suppliers of anti-retroviral APIs and intermediates. Our low-cost technologies in this critical segment are helping increase access to affordable medicine for patients around the world. We work closely with leading innovators, global health organizations, and providers to meet cost reduction targets, without compromising quality standards.

Oncology is one of our core competencies. We offer a comprehensive range of APIs in this segment. Our state-of-the-art facilities are capable of handling high-potent materials at both development and commercial scale. Laurus is continuously extending its portfolio by focusing on molecules in diabetes, ophthalmology, and cardio-vascular therapy areas, where we can make a difference and establish a leadership position.

We offer our globally compliant cGMP facilities, along with our chemistry expertise, to customers for contract development and manufacturing of APIs and intermediates. We are already a preferred CRAMs partner to several customers, owing to our stringent quality and EHS systems, wide operability range (from grams to multi-tonnage scale), robust project management practices, and vast contract manufacturing experience. With proven capabilities, we provide an end-to-end API solutions to global markets that meet and exceed the quality, regulatory and IP requirements as well as cost targets.